Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
From CNBC.com News
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
From CNBC.com News
Why Americans are outraged over health insurance — and what could change
December 18, 2024
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
December 17, 2024
From CNBC.com News
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'
December 13, 2024
From CNBC.com News
Health care stocks fall as lawmakers, patients push for changes to their business models
December 11, 2024
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
From CNBC.com News
Insurance stocks have fallen since UnitedHealthcare CEO's killing
December 10, 2024
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.